Overview

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Status:
Completed
Trial end date:
2019-03-26
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether contezolid acefosamil is as safe and effective as linezolid in the treatment of adult patients with acute bacterial skin and skin structure infections
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
MicuRx
Treatments:
Linezolid
Criteria
Inclusion Criteria:

- Patients with systemic signs of infection diagnosed with acute bacterial skin and skin
structure infection (ABSSSI)

- Diagnosed with cellulitis/erysipelas, major cutaneous abscess, or wound infections

Exclusion Criteria:

- Uncomplicated skin infections

- Severe sepsis or septic shock

- ABSSSI solely due to Gram-negative pathogens

- Prior systemic antibiotics within 96 hours of randomization